NIH-funded research P01 program project

Centralized bioinformatics support for HIV research

Official title: Computational Core

Funded at Beth Israel Deaconess Medical Center · NIH-11084515 · Data updated 2026-11-12

This study is all about using advanced data analysis to help researchers better understand HIV and find ways to improve treatments, so if you're interested in how science can make a difference in fighting HIV, this research is for you!

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 11, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$237,700
NIH project number5P01AI177687-03
Project IDNIH-11084515 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are seeking innovative treatment options or are involved in clinical trials.

Less likely to help

Patients who are not living with HIV or those who are not engaged in clinical research may not benefit from this research.

What this research studies

This research focuses on providing centralized statistical and bioinformatics services to support various projects aimed at understanding HIV. It involves analyzing genomic and spatial data to identify cellular signatures that could predict the effectiveness of interventions against HIV. The team will utilize established computational methods to ensure high-quality data analysis and will collaborate closely with researchers throughout the study. By integrating data from different sources, the goal is to enhance our understanding of HIV and improve treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for targeting HIV viral reservoirs, potentially enhancing treatment outcomes for patients living with HIV.

How similar studies have gone: Previous research utilizing computational methods for analyzing HIV data has shown promise, indicating that this approach could yield significant insights.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Ma, Qin — Beth Israel Deaconess Medical Center
  • Study coordinator: Ma, Qin

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.